Evidence map›Paper›PMID 38033295›Full record

ArticleACS nano2023

Nanoprojectile Secondary Ion Mass Spectrometry Enables Multiplexed Analysis of Individual Hepatic Extracellular Vesicles.

Seonhwa Lee, Dmitriy S Verkhoturov, Michael J Eller, Stanislav V Verkhoturov, Michael A Shaw, Kihak Gwon, Yohan Kim, Fabrice Lucien, Harmeet Malhi, Alexander Revzin and 1 more

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Seonhwa LeeDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, United States.
Dmitriy S VerkhoturovDepartment of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Michael J EllerDepartment of Chemistry and Biochemistry, California State University Northridge, Northridge, California 91330, United States.ORCID 0000-0002-9069-2180
Stanislav V VerkhoturovDepartment of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Michael A ShawDepartment of Chemistry and Biochemistry, California State University Northridge, Northridge, California 91330, United States.ORCID 0009-0001-1585-1380
Kihak GwonDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, United States.
Yohan KimDepartment of Urology, Mayo Clinic, Rochester, Minnesota 55905, United States.
Fabrice LucienDepartment of Urology, Mayo Clinic, Rochester, Minnesota 55905, United States.
Harmeet MalhiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, United States.
Alexander RevzinDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, United States.ORCID 0000-0002-8737-3250
Emile A SchweikertDepartment of Chemistry, Texas A&M University, College Station, Texas 77843, United States.ORCID 0000-0003-3964-7998
Mayo Clinic · USTexas A&M University · USCalifornia State University, Northridge · US

Funding

Pathobiology of Liver InjuryR01DK111378 · NIDDK · MAYO CLINIC ROCHESTER · PI MALHI, HARMEET · 2016 to 2025
$3.9M
Mass spectrometry for highly sensitive and sample-sparing analysis of extracellular vesicles in liver diseasesR01DK134661 · NIDDK · MAYO CLINIC ROCHESTER · PI Alexander Revzin, EMILE Alfred SCHWEIKERT · 2023 to 2026
$2.6M
Context rich mass spectrometry of molecular localization and cellular interactionsR01GM123757 · NIGMS · MAYO CLINIC ROCHESTER · PI REVZIN, ALEXANDER, SCHWEIKERT, EMILE ALFRED · 2017 to 2020
$2.1M
A microfluidic cell culture platform for personalizing pancreatic cancer therapiesR21CA236612 · NCI · MAYO CLINIC ROCHESTER · PI REVZIN, ALEXANDER · 2020 to 2021
$582k
NCI NIH HHS R21 CA236612NIDDK NIH HHS R01 DK111378NIDDK NIH HHS R01 DK134661NIGMS NIH HHS R01 GM123757
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are nanoscale lipid bilayer particles secreted by cells. EVs may carry markers of the tissue of origin and its disease state, which makes them incredibly promising for disease diagnosis and surveillance. While the armamentarium of EV analysis technologies is rapidly expanding, there remains a strong need for multiparametric analysis with single EV resolution. Nanoprojectile (NP) secondary ion mass spectrometry (NP-SIMS) relies on bombarding a substrate of interest with individual gold NPs resolved in time and space. Each projectile creates an impact crater of 10-20 nm in diameter while molecules emitted from each impact are mass analyzed and recorded as individual mass spectra. We demonstrate the utility of NP-SIMS for

Indexed as

Extracellular VesiclesLiver NeoplasmsCell LineHumansSpectrometry, Mass, Secondary Ioncancer biomarkersEV surface markersextracellular vesicleshepatocellular carcinomamultiplexed detectionnanoprojectile secondary ion mass spectrometry

Identifiers

PMID38033295
PMCPMC10985841
OpenAlexW4389163863

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.